Skip to content

Rule out malignancy in breast calcifications using computed tomography

Photon Counting CT scan to rule out malignancy in breast calcifications - PCBC study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON61301
Enrollment
50
Registered
2026-01-08
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer Breast cancer

Interventions

CT scan with contrast&nbsp
MRI scan with contrast&nbsp

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients must have given written informed consent Women aged 18 years and older who received a BI-RADS score of 4 or 5 due to suspicious calcifications detected on mammography during breast cancer screening

Exclusion criteria

Exclusion criteria: History of allergic reactions to iodinated or gadolinium contrast agents Pregnancy or breast feedingContraindications for MRI such as metal implants, pacemakers, implantable cardioverter defibrillator (ICD), claustrophobiaRecent treatment  (<8 weeks ago) of thyroid disease with radioactive iodineUse of metforminRenal Impairment (eGFR < 30 mL/min)Chronic or acutely worsening renal diseasePatients who are declared incompetent 

Design outcomes

Primary

MeasureTime frame
PCCT scan with contrast vs mammographyAssessment of  calcifications (feasibility, distribution, and morphology) on PCCT using reader assessment protocol. The results will be compared with mammography.DCE-MRI vs PCCT with contrast Assessment of contrast enhanced areas in  breast on PCCT and DCE-MRI Sensitivity, specificity, positive and negative predictive value of PCCT and DCE-MRI will be calculated. Histopathology will serve as the reference. 

Secondary

MeasureTime frame
Evaluate patient preferences, comfort levels, and confidence in diagnostic outcomes for PCCT, DCE-MRI, and stereotactic VABB using a validated, patient-informed multiple-choice questionnaire.

Countries

Netherlands

Contacts

Public ContactS.D. Joomun

Universitair Medisch Centrum Groningen

s.d.joomun@umcg.nl+31 6 46127925

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 23, 2026